Skip to main content
. 2018 Nov 14;13(11):e0205644. doi: 10.1371/journal.pone.0205644

Table 2. Association of demographic data and interleukin polymorphism with GERD status.

Variables Total GERD (%) Total Non-GERD (%) Crude OR OR (95% CI) P Value
Sex
 Male 28 (63.6) 16 (36.4) 2.00 0.902–4.436 0.088
 Female 28 (46.7) 32 (53.3) 1.00
Age
 <30 10 (66.7) 5 (33.3) 2.57 0.714–9.255 0.148
 31–40 10 (50.0) 10 (50.0) 1.29 0.419–3.944 0.660
 41–50 12 (57.1) 9 (42.9) 1.71 0.564–5.208 0.342
 >60 10 (62.5) 6 (37.5) 2.14 0.627–7.329 0.224
 51–60 14 (43.8) 18 (56.3) 1.00
BMI
 <18.5 5 (38.5) 8 (61.5) 1.00
 18.5–24.9 31 (51.7) 29 (48.3) 1.71 0.502–5.832 0.391
 25–29.9 13 (61.9) 8 (38.1) 2.60 0.627–10.786 0.188
 >30 7 (70.0) 3 (30.0) 3.73 0.646–21.577 0.141
Economic
 < Rp1,5M 6 (28.6) 15 (71.4) 1.00
 Rp 1.5M–Rp 5M 29 (58.0) 21 (42.0) 3.08 1.018–9.289 0.046*
 > Rp 5M 21 (63.6) 12 (36.4) 4.08 1.241–13.431 0.021*
Smoking
 Yes 19 (76.0) 6 (24.0) 3.60 1.298–9.955 0.014*
 No 37 (46.8) 42 (53.2) 1.00
Alcohol
 Yes 6 (85.7) 1 (14.3) 5.64 0.654–48.619 0.115
 No 50 (51.6) 47 (48.5) 1.00
Diabetes
 Yes 6 (75.0) 2 (25.0) 2.76 0.530–14.366 0.228
 No 50 (52.1) 46 (47.9) 1.00
Hypertension
 Yes 14 (60.9) 9 (39.1) 1.44 0.562–3.713 0.445
 No 42 (51.9) 39 (48.2) 1.00
Ethnicity
 Java 38 (57.6) 28 (42.4) 1.81 0.740–4.422 0.193
 Other 4 (66.7) 2 (33.3) 2.67 0.417–17.046 0.300
 Dayak 2 (50.0) 2 (50.0) 1.33 0.164–10.867 0.788
 Chinese 12 (42.9) 16 (57.1) 1.00
Religion
 Islam 43 (60.6) 28 (39.4) 4.61 0.868–24.464 0.073
 Christian 11 (55.0) 9 (45.0) 3.67 0.590–22.783 0.163
 Catholic 2 (25.0) 6 (75.0) 1.00
 Other 0 (0.0) 5 (100)
Marital Status
 Married 48 (54.6) 40 (45.5) 1.20 0.413–3.485 0.737
Not married 8 (50.0) 8 (50.0) 1.00
Toilet
 Toilet 55 (53.4) 48 (46.6)
 Non-toilet 1 (100) 0 (0.0)
PPI
 Yes 41 (62.1) 25 (37.9) 2.52 1.109–5.703 0.027*
 No 15 (39.5) 23 (60.5) 1.00
Antibiotic
 Yes 11 (55.0) 9 (45.0) 1.60 0.398–2.822 0.908
 No 45 (53.6) 39 (46.4) 1.00
NSAID
 Yes 15 (62.5) 9 (37.5) 1.59 0.622–4.040 0.334
 No 41 (51.3) 39 (48.8) 1.00
Sambal Intake
 Yes 28 (56.0) 22 (44.0) 1.18 0.546–2.559 0.672
 No 28 (51.9) 26 (48.2) 1.00
H. pylori infection
 Positive 2 (100) 0 (0.0)
 Negative 54 (52.9) 48 (47.1)
Antrum Atrophy
 Yes 11 (84.6) 2 (15.4) 0.18 0.037–0.848 0.030*
 No 45 (49.5) 46 (50.6) 1.00
Corpus Atrophy
 Yes 1 (50.0) 1 (50.0) 1.17 0.071–19.225 0.912
 No 55 (53.9) 47 (46.1) 1.00
OLGA Score
 Normal 44 (49.4) 45 (50.6) 1.00
 Stage 1 12 (80.0) 3 (20.0) 4.09 1.080–15.493 0.038*
 Stage 2 0 (0.0) 0 (0.0)
 Stage 3 0 (0.0) 0 (0.0)
 Stage 4 0 (0.0) 0 (0.0)
IL-1β Polymorphism
 TT 21 (48.8) 22 (51.2) 1.00
 CC 14 (56.0) 11 (44.0) 1.33 0.495–3.590 0.569
 CT 21 (58.3) 15 (41.7) 1.47 0.601–3.580 0.400
T Carrier IL-1β
 T carrier 32 (46.4) 37 (53.6) 1.00
 CC 24 (68.6) 11 (31.4) 1.12 0.454–2.771 0.804
C Carrier IL-1β
 TT 21 (48.8) 22 (51.2) 1.00
 C carrier 35 (57.4) 26 (42.6) 1.41 0.644–3.090 0.390
IL-8 Polymorphism
 TT 18 (48.7) 19 (51.4) 1.35 0.424–4.323 0.610
 AT 31 (62.0) 19 (28.0) 2.33 0.759–7.158 0.139
 AA 7 (41.2) 10 (58.8) 1.00
T Carrier IL-8
 T carrier 49 (60.5) 38 (39.5) 1.84 0.642–5.289 0.256
 AA 7 (41.2) 10 (58.8) 1.00
A Carrier IL-8
 TT 18 (48.7) 19 (51.4) 1.00
 A carrier 38 (56.7) 29 (43.3) 1.38 0.618–3.096 0.430

*Statistically significant when P < 0.05.